ADAPTILENS ANNOUNCES $17.5M SERIES A FINANCING
meet the adaptilens team

Visionary inventors, innovative engineers, preeminent materials scientists, seasoned industry veterans and distinguished ophthalmologists.

filter team by:
liane

Liane Clamen, MD

Founder & CEO

Management Team
Board
About Liane
Linkedin
Daniel-Stanley

Daniel Stanley, MS

Chief Operating Officer

Management Team
About Dan
Linkedin
brett-thomes

Brett Thomes, PhD

Chief Information and Technology Officer

Management Team
About Brett
Linkedin
Gianna-Hoffman-Luca

Gianna Hoffman-Luca, PhD

Board

Senior Principal, Venture, Perceptive Advisors

About Gianna
Linkedin
William-F-Shea-MBA

William F Shea, MBA

Former CEO, New Dimensions in Medicine

Board
About Bill
Linkedin
Jamie-Goldstein-MBA

Jamie Goldstein

Founding Partner, Pillar VC

Board
About Jamie
Linkedin
John-Andres,-JD

John Andres, JD

Principal, John C Andres, LLC

Board Observer
About John
Linkedin
image

Robert ("Bob") Doris, JD, MBA

Founding Partner, Accanto Partners

Board Observer
About Bob
Linkedin

Jayanth Batchu, MEng

Entrepreneur in Residence, Xontogeny

Board Observer
About Jay
Linkedin
matthew-becker

Matthew L Becker, PhD

Professor, Duke University

Scientific Advisory Board
About Matt
Linkedin
Thomas-X-Neenan-PhD

Thomas X Neenan, PhD

Principal, Gray Door Partners LLC

Scientific Advisory Board
About Thomas
Linkedin
Brian-Levy-OD-MSc

Brian Levy, OD, MSc

Former CMO, Bausch & Lomb

Scientific Advisory Board
About Brian
Linkedin
shelia

Sheila Borboli-Gerogiannis, MD

Site Director, Mass Eye and Ear Longwood

Scientific Advisory Board
About Shelia
Linkedin
Thomas-Clinch-MD

Thomas Clinch, MD

Founding Partner, Eye Doctors of Washington

Scientific Advisory Board
About Tom
Linkedin
cindy

Cindy Chao, MD, PhD

Former Surgeon, Ophthalmic Consultants of Boston

Scientific Advisory Board
About Cindy
Linkedin

Just like a young, healthy human lens, our A-IOL is designed to restore the eye’s natural ability to focus at near, intermediate, and far distances.

More about our technology
Adaptilens is made possible with help from​
notice: The Adaptilens is in the development phase and is not yet approved for investigational or commercial use.

Follow our progress on

Linkedin

Liane Clamen, MD

Founder & CEO

A serial ophthalmic device inventor and an authority on the history of intraocular lenses (IOLs), Liane is the inventor of Adaptilens, the first truly biomimetic accommodating intraocular lens (A-IOL). Prior inventions include a punctal plug drug delivery system and an anterior capsulotomy device. Liane trained at the Harvard Ophthalmology Residency Program at the Massachusetts Eye and Ear. She received her MD and BA degrees from Harvard University.

Follow Liane:
Linkedin

Daniel Stanley, MS

Chief Operating Officer

With over 25 years of industry experience, Dan brings deep expertise in ophthalmic device development to Adaptilens. As former Director of Intraocular Lens (IOL) Development at Alcon, Dan shepherded more than 30 IOL products from ideation to market. He also led an R&D team that grew a medical device product line from $10M to $1B a year.

Earlier in his career, Dan was an Air Force Officer and rocket propulsion engineer.

Follow Dan:
Linkedin

Brett Thomes, PhD

Chief Information and Technology Officer

An industry veteran, Brett has spent more than 20 years in the ophthalmic device world, including at Alcon, where he was Senior Director of Process Development and Head of New Product Introduction. He led an R&D team that expanded the project portfolio by 3X and accelerated launch timelines by reducing the average product development life cycle by 60%. His award-winning track record of achievements include delivering a broad range of Class I/II/III medical devices to market. Brett comes to Adaptilens with extensive know-how in the R&D and manufacturing of IOLs.

Follow Brett:
Linkedin

Gianna Hoffman-Luca, PhD

Senior Principal, Venture, Perceptive Advisors

Gianna is a Senior Principal at Perceptive Advisors, where she assists in the management of Perceptive Xontogeny Venture Funds’ investments in life sciences companies, including investments in companies seeded and incubated at Xontogeny. Previously, Gianna built the competitive intelligence capabilities for gene therapy company Solid Biosciences and began her industry career as a patent agent with Choate, Hall & Stewart, LLP., servicing pharma and academic clients. Gianna earned her Ph.D. in Pharmacology from the University of Michigan Medical School and completed her M.S. and B.S. degrees at the University of California, Santa Cruz in Chemistry.

Follow Gianna:
Linkedin

William F Shea, MBA

Former CEO, New Dimensions in Medicine

Bill has over 40 years of medical device leadership. He has served as Chief Executive Officer for three medical companies, and as a Board Member for over a dozen other medical companies. Bill began his career at The Kendall Company (now part of Medtronic) and later served as CEO of New Dimensions in Medicine, The Clinipad Corporation, and Med-Ecom. Bill has also consulted on numerous medical device transactions representing entrepreneurs with innovative technologies that fit in the portfolios of larger strategic medical companies.

Follow Bill:
Linkedin

Jamie Goldstein

Founding Partner, Pillar VC

Jamie is Founding Partner at Pillar VC. He has spent over two decades working in venture capital. Prior to Pillar, Jamie was an investing partner for 18 years at North Bridge Venture Partners.

Follow Jamie:
Linkedin

John Andres, JD

Principal, John C Andres, LLC

John is a patent attorney who has over 30 years of experience in the medical device industry in legal and business roles. He served as Chief Patent Counsel for US Surgical Corporation and as a Director for both Apyx Medical Corporation and K2M Inc.

Follow John:
Linkedin

Robert ("Bob") Doris, JD, MBA

Founding Partner, Accanto Partners

Bob is the Founding Partner of Accanto Partners, a seed-stage investor in startup companies. Previously, he founded and led Sonic Solutions from inception, as CEO (1986 – 2005) and later as Chairman (2005 – 2011). Sonic developed software and hardware tools for professional digital audio and digital video, with special focus on CD and DVD creation, and was recognized with a technical Emmy® award in 1996. Bob led Sonic’s successful IPO in 1994 and oversaw later developments as Sonic offered consumer tools for digital media creation including Roxio™ and Divx™ branded offerings, prior to the successful sale of Sonic to Rovi Corporation in 2011.

Follow Bob:
Linkedin

Jayanth Batchu, MEng

Entrepreneur in Residence, Xontogeny

Jay is a Senior Analyst / Entrepreneur in Residence at Xontogeny, leveraging his diverse skill set to aid the due diligence efforts of the Xontogeny investment team. Jay is experienced in building up multiple biotech and medtech ideas including cell therapies (cancer & autoimmune), engineered enzymes & antibodies, core needle biopsy devices, infectious disease diagnostics, and urinary microvalves. Jay received an AB degree in Economics from Dartmouth College, a BE degree in Biomedical Engineering and MEng degree in Biological/Chemical Engineering from Dartmouth’s Thayer School of Engineering.

Follow Jay:
Linkedin

Matthew L Becker

Professor, Duke University

Matt is the Hugo L. Blomquist Distinguished Professor of Chemistry, Biomedical Engineering, Mechanical Engineering and Materials Science and Orthopaedic Surgery at Duke University. He is a Fellow of the National Academy of Inventors, the American Chemical Society, the Royal Society of Chemistry and the American Institute of Medical and Biological Engineering.

He is the author of more than 220 publications and has more than 100 issued and pending patents worldwide.

Follow Matt:
Linkedin

Thomas X Neenan, PhD

Principal, Gray Door Partners LLC

Thomas is a founder of Nanite, Inc. a developer of polymeric nanoparticles for gene delivery. A serial entrepreneur, Thomas has served in founder and key management roles in a series of companies at the interface between materials sciences and biology including GelTex Pharmaceuticals (acquired by Genzyme), Warwick Effect Polymers (acquired by Polytherics), Panbela Therapeutics (NASDAX; PBLA) and AbFero Pharmaceuticals (acquired by Pharmacosmos). He is the author of 60+ publications and holds 45+ US and international patents.
Follow Thomas:
Linkedin

Brian Levy, OD, MSc

Former CMO, Bausch & Lomb

A preeminent leader in the field of Ophthalmology, Brian has extensive experience in Drug and Device Development. Brian was Chief Medical Officer of Bausch & Lomb and then Aerie Pharmaceuticals. He is currently Chief Executive Officer of OcuNexus Therapeutics, developing medications to treat chronic sight-threatening diseases.

He is a Clinical Professor in the Department of Ophthalmology at the University of Rochester’s School of Medicine and is the author of 50+ publications in peer-reviewed journals.

Follow Brian:
Linkedin

Sheila Borboli-Gerogiannis, MD, FACS

Director, Mass Eye and Ear Longwood

An Assistant Professor of Ophthalmology at Harvard Medical School, Shelia specializes in cataract surgery and corneal disease. Her primary focus as a medical educator is teaching cataract surgery to resident physicians. She is also Site Director of the Mass Eye and Ear Longwood and is a member of the Comprehensive Ophthalmology and Cataract Consultation Service at the Massachusetts Eye and Ear. Shelia trained at Harvard.

Follow Shelia:
Linkedin

Thomas Clinch, MD

Founding Partner, Eye Doctors of Washington

Tom is the founding partner of Eye Doctors of Washington. In more than 30 years of practice, he has performed over 40,000 LASIK and 20,000 cataract procedures. Throughout his award-winning career in ophthalmology, Tom has become known for providing innovative, state-of-the-art patient care. He has served as an investigator in more than 30 clinical studies pertaining to LASIK, PRK, and a variety of IOLs. He was educated at Cornell, Jefferson Medical College, and the Wills Eye Hospital.
Follow Tom:
Linkedin

Cindy Chao, MD, PhD

Former Surgeon, Ophthalmic Consultants of Boston

Cindy has more than 20 years of experience in clinical practice, most recently at Ophthalmic Consultants of Boston where she specialized in cataract surgery and corneal conditions. She completed her training at the Harvard Ophthalmology Residency Program at the Massachusetts Eye and Ear. She earned her MD and PhD in molecular genetics from Harvard after receiving her BS and MS from MIT.

Follow Cindy:
Linkedin